CAXTON CORP

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1388551 Princeton, NJ

Position in LXEO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$80,032

-$58,421 QoQ

Shares Held

13,943

0.0% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

1.99%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CAXTON CORP holds $396,089 across 5 Biotechnology names. LXEO ranks #2 (20.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYTX	Kyverna Therapeutics, Inc.	18,773	$162,010
2	LXEO	Lexeo Therapeutics, Inc. This page	13,943	$80,032
3	XFOR	X4 Pharmaceuticals, Inc	15,557	$64,250
4	IKT	Inhibikase Therapeutics, Inc.	28,453	$47,801
5	ALXO	Alx Oncology Holdings Inc	20,946	$41,996

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$80,032	13,943	0.0%	Shares	Sole	2026-05-14
2025-12-31	$138,453	13,943	-19.6%	Shares	Sole	2026-02-13
2025-09-30	$115,084	17,332	0.0%	Shares	Sole	2025-11-14
2025-06-30	$69,674	17,332	-2.9%	Shares	Sole	2025-08-14
2025-03-31	$61,942	17,851	0.0%	Shares	Sole	2025-05-15
2024-12-31	$117,459	17,851	0.0%	Shares	Sole	2025-02-14
2024-09-30	$161,373	17,851	0.0%	Shares	Sole	2024-11-14
2024-06-30	$286,330	17,851	+73.0%	Shares	Sole	2024-08-14
2024-03-31	$161,801	10,319	0.0%	Shares	Sole	2024-05-15
2023-12-31	$138,480	10,319	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.